Anterior Uveitis Treatment Market Growth & Trends
The global anterior uveitis treatment market size is expected to reach USD 967.5 million by 2030, registering a CAGR of 12.6% from 2024 to 2030. Rising prevalence of the disease is anticipated to aid market growth. This disease is more common when compared to panuveitis, posterior, and intermediate uveitis.
According to a 2017 article by Retina Today, this condition accounted for around 30% to 90% of the cases of uveitis. It also stated around 1% to 4% of patients experience 25% loss of visual acuity. There are different effective treatments for this disease and can be easily managed; however, it tends to recur. This disease is prevalent among both young and middle-aged group. It is also common among the geriatric population. Ocular ischemia and herpetic uveitis are the two most common causes of this disease among the geriatric population. Most of the cases occur in healthy people, however, some are associated with infectious diseases, gastrointestinal disorders, rheumatologic diseases, and lung & skin diseases. This disease is less sight-threatening as compared to posterior uveitis, however, in some cases might lead to glaucoma, cataract, and cystoid macular edema.
Anterior Uveitis Treatment Market Report Highlights
- Corticosteroids dominated the anterior uveitis treatment market in 2023 owing to its beneficial characteristic of minimizing inflammation in the eye. It is the primary treatment modality.
- Anti-TNF agents are expected to exhibit lucrative growth rate over the forecast period due to growing opportunity in treatment methods with biologic therapy using Anti-TNF drugs.
- Immunosuppressants held a significant market share in 2023 owing to their growing adoption for treatment of chronic anterior uveitis.
- Hospital pharmacies dominated the market in 2023 due to the wide treatment options available there.
- Online pharmacies are expected to witness significant CAGR over the forecast period due to convenience, ease, and availability of discounted products.
- North America held the largest revenue share in 2023 owing to high prevalence as well as healthcare expenditure in this region.
- Asia Pacific is anticipated to exhibit lucrative growth during the forecast period due to the rising number of infectious diseases in developing countries of the region and growing disposable income.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Anterior Uveitis Treatment Market Variables, Trends, & Scope
Chapter 4. Anterior Uveitis Treatment Market: Type Estimates & Trend Analysis
Chapter 5. Anterior Uveitis Treatment Market: Therapy Estimates & Trend Analysis
Chapter 6. Anterior Uveitis Treatment Market: Distribution Channel Estimates & Trend Analysis
Chapter 7. Anterior Uveitis Treatment Market: Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
Companies Mentioned
- Novartis AG
- Santen Pharmaceutical Co., Ltd.
- AbbVie Inc.
- Kiora Pharmaceuticals, Inc.
- Clearside Biomedical
- Aldeyra Therapeutics, Inc.
- Aciont Inc.
- Sirion Therapeutics, Inc.
- UCB S.A.
- Lux Biosciences, Inc.
- Tarsier Pharma Ltd.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | August 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 431.1 Million |
| Forecasted Market Value ( USD | $ 967.5 Million |
| Compound Annual Growth Rate | 12.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
